| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0022 | 0.9 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0093 | 1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.0028 | 1 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | Tipifarnib | FIMM | pan-cancer | AAC | -0.0076 | 1 |